Summary
Check out our latest interview with SOPHiA GENETICS, a company revolutionizing healthcare by leveraging data-driven technology to improve the diagnosis and treatment of cancer and rare diseases. In this conversation with Paul Chilo, Director of Governance, Risk & Compliance, we explore UNITY, a global oncology platform, and discuss the compliance strategy behind this international initiative, as well as our collaboration in making it a reality.
Here is the latest interview with one of our clients - SOPHiA GENETICS,. SOPHiA GENETICS was founded in 2011 by biologists who saw an opportunity to address the growing need for answers to diseases of the DNA.
They believed technology could make a positive and lasting impact on the world, using data for good.Their vision was to build a future in which each patient has equal access to world-class care, and today, they are well underway to realizing that impact. SOPHia has built a technology platform that distills complex data into actionable insights to reshape the way that cancer and rare inherited disorders are diagnosed and treated.
In this interview with Paul Chilo, Director of Governance, Risk & Compliance at SOPHiA GENETICS, we explore the latest initiative, UNITY, a global oncology platform. We discuss SOPHiA GENETICS’ compliance strategy for this international project, as well as our collaboration and partnership in bringing it to life.
FAQs
Our frequently questions
Find out how iliomad can help your company.
Only visible in production
Safety Reporting Personal Data in Clinical Trials: GDPR Obligations and Cross-Border Risks
Understand GDPR obligations for safety reporting personal data in clinical trials, including adverse event disclosure timelines, cross-border transfer rules and sponsor duties.
Weekly Digest: Healthcare Cyber Breaches, AI Regulation Advances and Genetic Data Enforcement | iliomad
Ransomware mortality data, the FDA-EMA AI framework, Germany's KI-MIG, the EU-US DPF under review and a wave of US healthcare breaches: this week's digest for biotech and healthtech.
EU Digital Omnibus Simplifies AI Act Obligations; Rhode Island Enacts AI Healthcare Laws
Regulation (EU) 2026/1744 streamlines EU AI Act compliance, while Rhode Island enacts three AI healthcare laws. Key updates for biotech and healthtech teams.
